Table 2.
Week-T3 dose | N | M | SD | Minimum | Maximum |
---|---|---|---|---|---|
A. T3 (ng/dL) concentrations over time | |||||
Baseline | 18 | 99.54 | 22.90 | 77.20 | 174.60 |
Wk 1–15 | 18 | 100.53 | 36.12 | 60.40 | 194.20 |
Wk 2–15 | 18 | 91.91 | 40.16 | 38.00 | 183.00 |
Wk 3–30/45 | 18 | 101.02 | 30.62 | 50.50 | 173.90 |
Wk 4–30/45 | 18 | 98.51 | 33.47 | 69.90 | 189.50 |
Wk 5–30/45 | 18 | 94.44 | 30.70 | 62.60 | 183.80 |
Wk 6–30/45 | 18 | 96.14 | 32.16 | 59.60 | 184.60 |
B. TSH (mIU/L) concentrations over time | |||||
Baseline | 18 | 1.56 | 0.81 | 0.19 | 3.28 |
Wk 1–15 | 18 | 2.00 | 1.95 | 0.22 | 7.80 |
Wk 2–15 | 18 | 5.90 | 5.74 | 0.20 | 19.00 |
Wk 3–30/45 | 18 | 5.87 | 9.10 | 0.08 | 31.40 |
Wk 4–30/45 | 18 | 2.93 | 2.96 | 0.07 | 10.70 |
Wk 5–30/45 | 18 | 3.36 | 4.12 | 0.07 | 16.50 |
Wk 6–30/45 | 18 | 3.84 | 3.66 | 0.04 | 12.00 |
C. fT4 concentrations (ng/dL) over time | |||||
Baseline | 18 | 1.19 | 0.24 | 0.84 | 1.90 |
Wk 1–15 | 18 | 0.78 | 0.21 | 0.58 | 1.40 |
Wk 2–15 | 18 | 0.61 | 0.22 | 0.34 | 1.06 |
Wk 3–30/45 | 18 | 0.51 | 0.24 | 0.10 | 1.02 |
Wk 4–30/45 | 18 | 0.47 | 0.26 | 0.17 | 0.99 |
Wk 5–30/45 | 18 | 0.45 | 0.28 | 0.15 | 1.00 |
Wk 6–30/45 | 18 | 0.44 | 0.31 | 0.10 | 1.03 |
SD, standard deviation; T3, triiodothyronine; fT4, free thyroxine.